Biomarkers will revolutionize the way we diagnose and treat Alzheimer's disease.
Goate
Alison
A
Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA. goatea@psychiatry.wustl.edu
Holtzman
David M
DM
D000544:Alzheimer Disease / Q000134:cerebrospinal fluid / Q000175:diagnosis* / Q000628:therapy; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid; D015415:Biomarkers / Q000134:cerebrospinal fluid*; D006801:Humans; D016875:tau Proteins / Q000134:cerebrospinal fluid
D016229:Amyloid beta-Peptides; D015415:Biomarkers; C054369:MAPT protein, human; D016875:tau Proteins